Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 42,000 shares at $20.55 ($882K) on 2023-02-09, disclosed to the SEC on 2023-02-09.
Open-market sale of $882k RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.45 | 14,000 | $300K | 34.1% |
| 2 | $20.98 | 14,000 | $294K | 33.3% |
| 3 | $20.55 | 14,000 | $288K | 32.6% |
| Total | $20.99 avg | 42,000 | $882K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |
| RLAY | SELL | 2025-11-04 | $435K | — | Filing → |